New compound 'highly efficacious' at reducing human tum...( Innsbruck Austria: Treatment with a ne...)

Innsbruck, Austria: Treatment with a new dual cell cycle and angiogenesis pathway inhibitor blocks VEGF-induced vascular permeability, inhibits tumour angiogenesis and induces apoptosis in human tumour models said Dr. Gerhard Siemeister of Schering AG, Corporate Research, Berlin speaking at the 18th meeting of the European Association of Cancer Research today (Tuesday 6 July, 2004).

Loss of cell cycle control (runaway growth) and tumour-induced angiogenesis (development of new blood vessels to supply the growing tumour with oxygen) are two major hallmarks of cancer. Loss of cell cycle control as a consequence of aberrant cyclin-dependent kinase (CDK) control has been directly linked to the molecular pathology of cancer. CDK's are a family of enzymes required for the correct timing and order of events in the cell division cycle. Vascular endothelial growth factor (VEGF) / VEGF-receptor tyrosine kinase (VEGF-RTK) and platelet-derived growth factor (PDGF)-RTKs are two molecules known to be involved in tumour angiogenesis.

The new compound, called 'ZK-CDK', is a novel, chemically synthesized small molecule ATP-competitive kinase inhibitor that is unique in that combines the inhibition of tumour cell growth as well as inhibition of tumour angiogenesis in one single molecule.

ZK-CDK was shown to inhibit a range of CDK's as well as VEGF-RTK's and PDGF-RTK's resulting in an inhibition of the proliferation of human tumour cell lines in vivo. ZK-CDK blocked cell cycle progression in G1 and induced apoptosis, blocked VEGF-induced vascular permeability in vivo and reduced the blood supply of human tumour xenografts. "These animal data are very promising in terms of anti-tumour efficacy and tolerability", said Dr. Siemeister. "VEGF-RTK inhibitors have been shown to be well-tolerated by patients and we hope that ZK-CDK will be well tolerated. The CDK inhibiting mechanism of ZK-CDK, in contrast to cytotoxic chemotherapy, should arrest the proliferation of
'"/>

Contact: Stuart Bell
stuart@fecs.be
00-32-0-495-27-2838
Federation of European Cancer Societies
6-Jul-2004

Page: 1 2
Related biology news :

1. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
2. NJIT chemist speaks Aug. 25 about compound derived from pine tree
3. New compound could give some types of cancer the one-two punch
4. Scientists identify compounds that mimic calorie restriction
5. Firefly compound lights up protein dance in living animals
6. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
7. New screening method turns up potential compound for treating anthrax
8. New, non-radioactive screen for antimalarial compounds
9. OHSU team discovers compound that lacks estrogens risks
10. Three molecular-targeted compounds show promise against cancers
11. New compound library to speed drug discovery